Crazy to think it’s dilution now that more atypical companies are funded? I also have genuine concerns with the quality of evaluation in bio fields but when we

Crazy to think it’s dilution now that more atypical companies are funded? I also have genuine concerns with the quality of evaluation in bio fields but when we make criticism that can also be explained by bias then we critics have a burden to clarify if we gave enough thought to that possibility that we are just offended by the new.